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Objectives. (i) To determine the feasibility of using actigraphy to identify sleep 
interruption in children with suspected obstructive sleep apnea (OSA); (ii) to assess 
the utility of actigraphy for prediction of OSA severity.   
Subjects and Methods. Ten healthy children aged 2 to 15 years with suspicion for 
OSA underwent polysomnography (PSG) with actigraphy. Statistical learning 
algorithms were used to (i) identify sleep-related respiratory events (awake, asleep, 
hypopneas, and apneas), and (ii) predict OSA severity (mild, moderate, and severe) 
utilizing actigraphy counts.   
  
Results. No adverse events were identified. Actigraphy counts were obtained in all 10 
children. Linear discriminant analysis identified 100% of patients with severe OSA. 
Actigraphy counts reliably identified hypopneas and awakenings but not apneas. 
Conclusions. Actigraphy counts may provide effective risk stratification for pediatric 
OSA. Further investigations are necessary to investigate the utility of using 
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Chapter 1: Introduction 
Background 
Sleep Disordered Breathing  
Sleep disordered breathing (SDB) in children is a spectrum of abnormal breathing 
patterns, characterized by a limitation of airflow during sleep. Upper airway 
resistance and collapse of the pharynx can cause varying degrees of obstruction, 
which can be exacerbated by the presence of adenotonsillar hypertrophy, obesity, and 
craniofacial or neuromuscular disorders. The spectrum of SDB ranges from primary 
snoring (PS), to upper airway resistance syndrome (UARS), to the most severe 
diagnosis of obstructive sleep apnea (OSA).1 Obstructive sleep apnea can be further 
stratified into mild, moderate, and severe categories. This spectrum is based on the 
frequency and severity of airflow obstructions, arousals, and gas exchange 
abnormalities during sleep.1 
 
The prevalence of sleep disordered breathing has increased over the past 2 decades, 
associated with increases in obesity rates among children. A meta-analysis estimated 
the prevalence of SDB to be about 7.45%, with an underlying assumption that a large 
proportion of children with SDB remain undiagnosed.2 Studies indicate that SDB has 
been shown to have increased prevalence among obese children,3 African-American 






Sleep disordered breathing is diagnosed clinically by history and physical 
examination as the initial method to establish the site of obstruction. Habitual snoring, 
weight and body habitus, tonsil size, tongue position, mouth breathing, drooling, 
neuromuscular deficits, and other findings can all indicate the presence of SDB.6 
Definitive diagnosis of the type of SDB is determined by polysomnography (PSG) or 
sleep study.  
 
Treatment of SDB depends on the etiology of obstruction. Pharmacotherapy, such as 
intranasal steroids to reduce upper airway inflammation, can be used to treat mild 
disease.7 Positive airway pressure (PAP) can be an effective therapy, although the 
compliance among children is poor.8 Orthodontic treatments such as rapid maxillary 
distraction (RMD), have also been tested with varying degrees of effectiveness, 
depending on compliance and the type of SDB present.9  Surgical therapy remains the 
first-line treatment for more severe disease. 
Pediatric Obstructive Sleep Apnea Syndrome  
Pediatric OSA is the most severe form of SDB and is characterized by increased 
upper airway resistance, followed by intermittent partial or complete upper airway 
obstruction, which disrupts normal ventilation and sleep patterns. The prevalence of 
OSA is estimated to be up to 5% in children.2 The principal risk factor for pediatric 
OSA is the pathologic enlargement of the lymphoid tissue within the tonsils and 
adenoids,10 as seen in Fig. 1. Other less common risk factors for OSA include 





enlarged lymphoid tissue leads to increased airway resistance and collapse, and 









Figure 1: Image of the palatine tonsils (T) showing restricted dimensions of the 
oropharyngeal airway (picture courtesy of Dr. Amal Isaiah).  
 
Pediatric OSA is characterized by repeated episodes of partial or complete airway 
obstruction during sleep, resulting in a cycle of hypoxemia, respiratory compensation, 
heart rate variability, and awakening.6 Left undiagnosed or untreated, the earliest 
adverse effects of OSA include neurobehavioral problems12 and cognitive 
dysfunction.13 Currently, the gold standard for diagnosis is an overnight laboratory-
based PSG.14 The principal metric derived from a PSG is the apnea-hypopnea index 
(AHI), which reflects the severity and frequency of airflow limitation. Although there 
is no universally accepted grading system for OSA, an AHI greater than 1 but less 
than 5 is considered mild, greater than or equal to 5 but less than 10 is considered 
moderate, and a value greater than or equal to 10 is considered severe.15 







significant improvement or resolution of symptoms in the majority of children with 
OSA.16 With over 500,000 performed each year in the United States, T&A is one of 
the most common surgical procedures performed in children.17 
 
Due to the effects of chronic airway obstruction and hypoxemia on brainstem 
respiratory control mechanisms, children with OSA are more prone to perioperative 
respiratory adverse events (PRAEs), and may require overnight admission following 
surgery.18 The most recent guidelines from the American Academy of 
Otolaryngology—Head and Neck Surgery (AAO-HNS) recommend overnight 
monitoring for children with AHI ≥ 10.19 Although PSG is helpful in the 
identification and stratification of children with OSA prior to T&A, obtaining a PSG 
for every child undergoing the procedure is not feasible. This is due to the enormous 
need for financial, personnel, and technical resources. In fact, only about 10% of 
children undergoing T&A receive a preoperative PSG.20 In addition, children without 
risk factors for OSA may have unexpectedly severe OSA (AHI ≥ 30), emphasizing 
the need for preoperative risk stratification.21 Therefore, an ideal screening process 
balances cost-effectiveness and improved risk stratification of OSA so that eligible 
children may undergo further objective assessment utilizing PSG. 
Sequelae of Untreated OSA 
Many short- and long-term sequelae associated with untreated OSA in children 
support prompt diagnosis and initiation of early treatment. Cha et al.22 demonstrated 
significant correlation between AHI and mean diffusivity in select regions within the 





and contributes to several higher brain functions including learning, memory, and 
spatial coding. A lower mean diffusion of water within the dentate gyrus, as measured 
by diffusion tensor imaging, correlated with AHI and was associated with a lower 
verbal learning and memory score on neuropsychological assessments. Gatica et al.23 
established a negative correlation between sleep-related breathing disorders and 
academic performance in young children. Significant associations were observed 
between sleep-related breathing disorders and low performances in math, language 
arts, and science. Furthermore, a study by Landau et al.24 found that preschool-aged 
children with OSA demonstrated significantly impaired executive function, attention, 
and receptive vocabulary; had more behavioral problems; and scored lower on a 
health-related quality of life questionnaire than matched controls.  
 
Long-term OSA is associated with sequelae beyond neuropsychiatric and behavioral 
issues. Nieminen et al.25 found that children with OSA had significant impairments in 
secretions of different growth hormones. Adenotonsillectomy resulted in weight gain 
and restored hormone secretion. Peña-Zarza et al.26 found that increasing glycated 
hemoglobin (HbA1C), which is a useful homeostatic biomarker of blood-glucose 
levels, was associated with increasing AHI. High blood glucose levels are pathologic 
for diabetes. Although both diabetes and OSA have associations with obesity, the 
correlations between HbA1C and AHI remained significant when adjusting by age and 






Diagnosis of OSA 
History and Physical Examination  
A summary of the presenting signs and symptoms of OSA is provided in Table 1 
below. Adolescents and older children may be able to recognize these problems and 
articulate complaints, whereas these symptoms may be reported by parents of 
younger children.  
Nighttime symptoms Frequent snoring (≥3 nights per week) 
Labored breathing during sleep 
Gasps/snorting noises/observed apneas 









Sleeping in seated position/with neck 
hyperextended 
Cyanosis  
Headache on awakening 
Daytime symptoms Daytime sleepiness 
Mouth-breathing 
Difficulty waking in the morning 
Poor eating/failure to thrive 
Symptoms attributable to attention 




Physical exam findings Obesity/above average BMI 
Elevated blood pressure 
Enlarged tonsils 






A number of studies have assessed the utility of history and physical examination 
findings, together referred to as clinical parameters, in predicting both the presence 
and the severity of OSA. For example, Wang et al.28 attempted to quantify the 
relationship between clinical findings and OSA, with predictive accuracy never 
exceeding 50%. These findings were additionally confirmed by a subsequent meta-
analysis. In the childhood adenotonsillectomy trial (CHAT),15 a randomized-
controlled trial comparing the benefit of early T&A and watchful waiting with 
supportive care, risk factors for OSA could be identified, but the association between 
these parameters and the severity of OSA could not be established. Furthermore, the 
use of validated instruments such as the pediatric sleep questionnaire29 and the OSA 
score30 have had some utility as research tools to determine the risk of OSA, although 
they have not universally supplanted objective testing. 
Screening Instruments 
A number of screening questionnaires have been developed to screen children for 
OSA. Brouilette et al.30 used a standardized questionnaire that demonstrated 
significantly increased frequencies of the following symptoms when compared to 
age- and sex-matched controls: difficulty breathing during sleep, apnea observed by 
the parents, snoring, restless sleep, chronic rhinorrhea (runny nose), and mouth 
breathing while awake. They developed the OSA-score using discriminant analysis. 
Scores over 3.5 were highly predictive of OSA requiring T&A, no child with a score 
less than -1 had OSA, and children with scores between -1 and 3.5 required PSG. 
Subsequent studies, however, have demonstrated that the OSA-score is limited in its 





Chervin et al.32 developed the Pediatric Sleep Questionnaire (PSQ), a 22-item 
questionnaire in which scores range from 0 to 1, with higher scores indicating greater 
severity. The PSQ items address snoring frequency and quality, breathing problems, 
mouth breathing, daytime sleepiness, inattention/hyperactivity, and other symptoms 
to identify children with SDB. They used logistical regression models to identify 
question-items most suitable for use in identifying SDB. Both sensitivity and 
specificity were high (0.85 and 0.87 respectively) when 8 or more positive answers to 
the 22 question items were considered abnormal. Although the PSQ can be used to 
identify patients at risk for OSA, it alone cannot diagnose or distinguish between 
mild, moderate and severe OSA.   
 
The OSA-18 quality-of-life questionnaire (OSA-18) is an 18-item questionnaire that 
uses a Likert-type scoring system to collect information considered to be elements in 
quality of life: sleep disturbance, physical symptoms, emotional symptoms, daytime 
function, and caregiver concerns. The output is a summary score that ranges from 18 
(no impact on quality of life) to 126 (major negative impact).33 While it can be 
helpful in aiding clinical diagnosis, the OSA-18 does not accurately detect which 
children have abnormal oximetry scores, and cannot be used in place of objective 
testing to identify moderate-to-severe OSA in children.34 
Home Sleep Apnea Testing (HSAT) 
Pulse oximetry has been explored as a diagnostic tool for OSA, as it provides 
information about oxygen desaturation during sleep, and can be analyzed quickly and 





summarize reference values of nocturnal oximetry parameters in healthy children, as 
well as to identify abnormal oximetry patterns that predict OSA in snoring children 
and treatment response or potential complications. They found that nocturnal pulse 
oximetry (SpO2) drops below 90% and clusters of more than two desaturation events 
≥ 4% were unusual in children without OSA. At least three clusters of desaturation 
events and three SpO2 drops below 90% are indicative of moderate-to-severe OSA. 
Children without clusters of desaturation events have low risk of major respiratory 
complications following T&A. Pulse oximetry can therefore be a valuable tool for 
evaluating OSA when PSG is not available.  
 
Lamm et al.36 explored the use of home audiotaping—15 minute recordings of the 
child’s sleep and breathing to distinguish between PS and OSA. Seven independent 
observers analyzed the recordings for the presence of a struggle sound and respiratory 
pauses. The mean sensitivity was 0.71, and the mean specificity was 0.80. Home 
audiotapes are suggestive of OSA, but not sufficiently specific to reliably distinguish 
PS from OSA.  
 
Jacob et al.37 investigated the accuracy and practicality of performing home sleep 
studies in 21 children. These home sleep studies included cardiorespiratory 
recordings of SpO2, pulse rate, pulse wave form, electrocardiogram, and respiratory 
inductive plethysmography (movement of the chest wall) in addition to an 8-hour 
recording of the child sleeping. These home sleep studies were validated against PSG. 





90.0% of the time, respectively. They also found that the sleep efficiency was 5% 
greater at home, while study duration, AHI, spontaneous movement/arousal index, 
and oxygen saturation were similar for home and laboratory studies. Home sleep 
studies can be accurate and practical in evaluating more severe OSA, but may fail to 
identify the presence of associated sleep disorders and partially obstructed breaths. 
Negative results do not rule out the diagnosis of OSA and should be followed with a 
PSG.38 Home PSG studies in children also lack standardization, making it difficult to 
study their effectiveness on a large scale. 
 
Due to insufficient data for validation, the American Academy of Sleep Medicine 
(AASM) has released position statements that assert that HSAT can provide valuable 
information for the diagnostic assessment of adult patients with suspected OSA,39 but 
the use of an HSAT is not recommended for the diagnosis of OSA in children.40 
Polysomnography 
Polysomnography is the electrographic recording of simultaneous physiologic 
variables during sleep. There is currently no consensus on when children with clinical 
suspicion for OSA are recommended to have PSG. The AAO-HNS recommends that 
children be referred for PSG prior to T&A if they exhibit complex medical conditions 
such as obesity, Down syndrome, craniofacial abnormalities, neuromuscular 
disorders, sickle cell disease, or mucopolysaccharidoses. A PSG should also be 
sought if surgery is uncertain, or if there is discordance between tonsillar size on 
physical exam and the reported severity of the SDB.19 The American Academy of 





signs of OSA be referred for PSG. If no PSG is available, an alternative diagnostic 
test should be performed, or the patient should be referred to a sleep specialist or 
otolaryngologist for further evaluation.11 
 
Polysomnography is performed at certified sleep centers where trained technicians 
administer the sleep studies and generate reports. Trained and certified sleep 
technicians score the reports, and a chief sleep physician provides quality review. 
Polysomnography measures a large number of variables, including: sleep stage, 
muscle tone, thoracoabdominal movement, airflow and nasal pressure, oxygen 
saturation, leg and chin movement, body position, and cardiac rhythm. A sample PSG 
is provided in Fig. 2, and explanations of measured variables as well as those 
interpreted by sleep technicians are provided in Tables 2 and 3.  
 
An apneic event is complete closure of the airway or cessation of breathing, while a 
hypopneic event is the partial closure of the airway or cessation of breathing. AHI is 
defined as the sum of all obstructive and mixed apneas and hypopneas divided by the 
total hours of sleep time. As mentioned previously, AHI is the primary parameter 
used to diagnose and determine the severity of OSA, as well as the treatment course, 
with mild disease more likely to be treated with intranasal corticosteroids7 and severe 
disease treated with surgery.  
 
Sleep studies are not universally available or accessible to patients due to shortages of 





al.41 estimated the cost for testing 1,000 patients by PSG to be approximately 
$1,000,000. Thus, there is a significant financial barrier to access. Providing every 
child suspected of SDB with a PSG is financially untenable. As a result of these 
factors, only 10% of all children suspected of SDB undergo preoperative PSGs prior 
to T&A.20 Thousands of children at risk for potential PRAEs are therefore not 
stratified prior to surgery. Therefore the diagnostic methodology for pediatric OSA is 

















































Parameter Variable Name Purpose 
Sleep stage W, R, N1, N2, N3, 
STAGE 
Wake, REM, Stage 1, 
Stage 2, Stage 3 
Electrooculography  LEOG, REOG Electrodes near eye help 
determine sleep stage  
Electroencephalography  F3M2, F4M1, C3M2, 
C4M1, O1M2, O2M1 
Electrodes on the scalp 
record brain activity and 
help determine sleep stage 
Electromyography  Chin, Chin 2, RLEG, 
LLEG 
Electrodes on chin and 
legs (or arms) measure 
muscle 
tensions/movement and 
help determine sleep stage 
Electrocardiography  ECG1 Electrodes on chest record 
heart beats  
Heart rate  HR Heart rate 
Pulse transit time PTT, PTTm, PTTv Indicator of arterial 
stiffness and blood 
pressure variability 
Oximetry  SpO2 Probe measures oxygen 
levels in the blood stream 
Microphone Micro Snoring and sleep sounds 
Respiratory effort THO, ABD, Sum Thoracoabdominal 
movement  
Positive airway pressure  Mask, CPRESS, EPAP, 
IPAP 





Ptaf, Ptaf 2, Therm Nasal and oral airflow 
Body position Body Supine, left, right 
Table 2: Parameters measured during overnight PSG. Variable names listed as 








Total sleep time (TST) Total time (in minutes) spent asleep 
Time in bed (TIB) Total time (in minutes) spent in bed 
Sleep efficiency (SE) Percentage of time spent asleep while 
in bed 
Sleep latency (SL) Time (in minutes) spent in bed before 
onset of sleep 
Wake after sleep onset (WASO) Total time spent awake in bed after the 
initial onset of sleep 
Obstructive apneas Number of total airway occlusions 
caused by obstruction (continued 
respiratory effort)  
Central apneas Number of total airway occlusions not 
caused by obstruction (no respiratory 
effort)  
Mixed apneas Total number of apneas  
Hypopneas Number of partial airway occlusions  
Apnea index Number of apneas per hour of sleep 
Hypopnea index Number of hypopneas per hour of sleep 
Apnea-hypopnea index (AHI) Number of apneas and hypopneas per 
hour of sleep 
Arousal index Number of arousals/awakenings per 
hour of sleep 
Oxygen desaturation index (ODI) Number of times per hour the blood 
oxygen level drops by a certain degree 
(typically 4%) from baseline 
SpO2 Nadir  The lowest oxygen saturation value the 
patient drops to  
Table 3: PSG parameters interpreted by sleep technicians according to the 







Actigraphy testing is the use of a small, portable device (actigraph) that uses an 
accelerometer to produce a signal in response to movement. The magnitude and 
duration of the signal depends on the magnitude of movement. These signals are 
digitized and stored as actigraphy counts, which can subsequently be analyzed. They 
can then be expressed graphically as actograms (Fig. 3) or numerically as total 
actigraphy counts per epoch (time interval of measurement, typically 30 seconds for 
studying sleep). An actiwatch is wrist-worn actigraph that may also be worn around 
the ankle or on the trunk. Actigraphy is used for the study of sleep patterns, based on 
the assumption that movement is reduced during sleep relative to being awake. 
Activity levels as measured by actigraphy can be used as a clinically-validated, non-
invasive, and relatively inexpensive method for studying sleep at home. Actigraphs 
estimate parameters such as TST, WASO and SE. Current clinical practice guidelines 
suggest the use of actigraphy in normal, healthy adult populations, or in patients 
suspected of specific sleep disorders such as advanced sleep phase syndrome, delayed 
sleep phase syndrome, shift work disorder, jet lag disorder, and non-24-hour 
sleep/wake syndrome. When PSG is not available, actigraphy may be used to 
characterize circadian rhythm disorders and insomnia, and can also be used to 
measure TST in patients with OSA.43 Due to lack of validation, actigraphy is 
currently not approved for use in children. Meltzer et al. found that actigraphy shows 
good sensitivity (0.88) and accuracy (0.84), but specificity was not as strong (0.46) in 





by combining actigraphy with other physiological data that do not need sleep staging, 
such as pulse oximetry.  
 
Figure 3: Sample actigram demonstrating a graphical display of actigraphy 
counts over the time of night.  
Current Models  
There are a number of different activity trackers and actigraphs currently on the 
market, such as the Motionlogger® Sleep Watch (Ambulatory Monitoring, Inc., 
Ardsley, NY), Actiwatch-2® (Philips Respironics, Amsterdam, NL), and commercial 
devices like the Fitbit Ultra® (Fitbit, San Francisco, CA) and UP® (Jawbone, San 
Francisco, CA). There are also more sophisticated devices, like the Actiwatch 
Spectrum Plus®, which has a watch-face display, longer battery life, and more 
memory for data storage. This device uses the same activity monitoring technology as 
the Actiwatch-2®. A more detailed description of different clinically validated devices 



























In a different study by Meltzer et al.,45 the Motionlogger® Sleep Watch and 
Actiwatch-2® were compared for sensitivity, specificity, and accuracy in measuring 
TST, WASO, and SE validated against PSG. They found that both devices 
significantly overestimated WASO, while the Motionlogger® Sleep Watch device 
significantly underestimated TST. Agreement with PSG differed depending on the 
scoring algorithm used for the Motionlogger® Sleep Watch and the sensitivity setting 
for the Actiwatch-2®. Another study by Meltzer et al.46 compared the Fitbit Ultra® 
with PSG, as well as the Motionlogger® Sleep Watch and Actiwatch-2®. Both the 
‘Normal’ and ‘Sensitive’ sleep-recording modes of the Fitbit® were tested. The 
normal mode showed good sensitivity (0.86) and accuracy (0.84), but poor specificity 
(0.52), while the sensitive mode had adequate specificity (0.79), but inadequate 
sensitivity (0.70) and accuracy (0.71). Neither sleep-recording mode provided 
clinically comparable results to PSG. A similar study by Toon et al.47 compared the 
commercial device UP®, as well as the MotionX 24/7® smartphone application 
(Fullpower, Santa Cruz, CA) to PSG and Actiwatch-2®. UP® showed good sensitivity 
(0.92) and accuracy (0.86), but poor specificity (0.66) when compared to PSG and 
was relatively analogous to the Actiwatch-2®. The MotionX 24/7® application did not 







































(MEMS) triaxial digital 
output motion sensor 
Solid state triaxial 3-axis MEMS 
Dimensions 3.5 x 3.5 x 1.5 5.6 x 3.8 x 1.3 3.6 x 3.6 x 1.2 3.81 x 2.54 x 1.016 
Light Sensor N/A N/A Photodiode Digital 
Battery Life 14 days (wireless & gyro 
disabled, 30Hz sample 
rate) 
Up to 5 nights between 
charges 
30+ days 120 days 
Memory 
Storage 
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Table 4: Examples of clinically validated actigraphs, their manufacturers, and 
some specifications. Note: this is not an exhaustive list, but a representative sample 
of available technologies.55 
 
Machine Learning (ML) 
Description 
Machine learning involves statistical modeling of complex data, facilitating 
identification of ‘rules’ from a dataset to improve predictive capabilities of any given 












3-axis MEMS Solid-state Piezo-electric 
accelerometer 
MEMS 
Dimensions 4.7 x 3.1 x 1.2 4.3 x 2.3 x 1.0 4.5 x 4.5 x 1.6 
Light Sensor RGB-IR Color light sensor Silicon photodiode NPN-phototransistor 
















statistical model. A dataset is partitioned into a test and training portions randomly 
(i.e., 20% and 80% of the original dataset, respectively). A chosen algorithm is 
trained on features (variables) associated with the training dataset. Subsequently, the 
rules generated by the training portion of the dataset are applied to the test dataset, 
and the metrics associated with classification determined.56 Machine learning 
techniques are used in the technology industry for applications such as facial 
recognition, targeted advertising, and reverse image searching. These methods have 
also been applied to address questions in the medical field, such as predicting protein 
folding57 or outcomes in radiation therapy.58 Algorithms such as support vector 
machine (SVM) have been used to analyze electroencephalogram (EEG), 
electrooculogram (EOG), and electromyogram (EMG) signals during a PSG in order 
to predict sleep stage. Sleep stage is normally scored manually by a trained technician 
as defined by the AASM 2012 clinical staging manual.59 The overall agreement 
between scoring performed by experts and the results of the ML algorithm was 
82.53%, demonstrating that these techniques can be used to predict manually scored 
sleep annotations. Other ML algorithms have been applied to sleep medicine to study 
the sleep-wake transition in narcolepsy,60 genes associated with circadian rhythms,61 
and sleep quality.62  
  
Machine learning is broadly classified into two categories: supervised and 
unsupervised learning. Supervised learning methods require the value of the output 
variable to be known for each training sample. These algorithms train a model that 





features in the process. If the output variables are continuous, then the model is called 
a “regression function,” whereas if the output variables are discrete, the model is 
called a “classifier.” Because the output is known, the performance of these models 
can be tested using a separate test dataset. Unsupervised learning techniques require 
only the input feature values in the training data. Clustering techniques that partition 
data into groups, such as K-means clustering, hierarchical clustering, and spectral 
clustering are examples of unsupervised learning.56 
Present Study 
Pediatric OSA is a common condition that may lead to long-term complications if left 
untreated. Objective characterization is necessary prior to surgery due to the risk of 
PRAEs. Unfortunately, the PSG is expensive and inaccessible to many patients. Due 
to the ease of use, we investigated the utility of wrist-based actigraphy as a surrogate 
for sleep fragmentation and respiratory event annotations obtained from a PSG, either 
alone or in combination with other easily obtainable physiological parameters (e.g., 
oximetry). We hypothesized that analysis of our results with machine learning 
algorithms may support a framework for risk stratification in pediatric OSA. We also 
hypothesized that the majority of the sleep annotations could be successfully 
identified. If successful, this project ultimately lays the groundwork for the 
development of budget-conscious actigraphs, using accelerometers and/or 






Chapter 2: Methods 
 
Subjects 
Children were included in this study based on (i) age (between 2 and 17 years old) 
and (ii) referral for a PSG based on clinical symptoms suspicious for OSA. Exclusion 
criteria included (i) presence of a neuromuscular disorder, (ii) presence of a 
craniofacial syndrome, (iii) previous history of upper airway surgery, or (iv) 
developmental delay. If a new diagnosis was made (e.g., severe asthma) during the 
course of testing, subjects were withdrawn.  
Data Collection 
The patient and caregiver were counseled on the study during the course of clinical 
evaluation in the outpatient facility at the University of Maryland Medical Center 
(UMMC). Consent was obtained from the caregiver and assent was obtained from 
appropriately aged children (age 12 and above). Demographic and clinical data, 
including age, ethnicity, insurance status, height, weight, tonsil size (1-4 scale), and 
presence of asthma, allergies, and gastroesophageal reflux disease (GERD) were also 
obtained during these clinical visits. The BMI was calculated from height and weight 
data and converted to percentiles and BMI z-scores using data charts from the Center 
for Disease Control and Prevention (CDC) for children aged 2 to 18 years old.63 All 
patients underwent full-night, in-laboratory PSG at the University of Maryland 
Pediatric Sleep Disorders Center, Baltimore, according to the AASM practice 
parameters.42 When children arrived at the sleep lab, an Actiwatch-2® was secured 





Variables obtained from PSG included TST, SE, SL, WASO, AHI, SpO2 nadir, 
arousal index, percentage of rapid eye movement (REM) and non-REM (NREM) 
sleep, and percentage of time spent in each stage of NREM sleep (N1, N2 and N3). 
Respiratory parameters such as apneas and hypopneas were obtained in 30-second 
epochs. Actigraphy data was exported to a computer-based software (Actiware, 
Philips Respironics, Amsterdam, NL) for analysis. Actigraphy counts were measured 
from Lights-Off time to Lights-On time, as well as from the start of Stage 2 sleep to 
the end of sleep time (estimated by adding TST, SL, and WASO). The activity during 
WASO was also estimated by identifying actigraphy counts during wake states. Wake 
states were indicated by the hypnogram obtained from the PSG recording. A total 
asleep actigraphy count was calculated by subtracting the WASO activity from the 
actigraphy count determined by sleep stage. A summary of respiratory events 















Parameter Definition How it is measured  
Actigraphy counts  Activity movement over 
thresholda 
Actiwatch-2® (30s epoch) 
Apnea ≥ 2 missed breaths, 
airflow reduction by > 
90%, rib cage and/or 
abdominal effort 
continues, associated with 
desaturations 
Oronasal thermistor, nasal 




Hypopnea ≥ 2 missed breaths, 
airflow reduction by > 
50%, rib cage and/or 
abdominal effort 
continues, associated with 
arousals or awakenings 
Oronasal thermistor, nasal 




Respiratory event with 
desaturation  
Drop from baseline SpO2 
preceding respiratory 
event, to the nadir in 
SpO2 following the event 
(> 3%) 
Pulse oximeter (30s 
epoch) 
Arousal Abrupt shift of 
EEG/EMG frequency 
including alpha, theta 
and/or frequencies > 
16Hz lasting at least 3s 
and preceded by at least 
10s of stable sleep 
EEG and EMG channels 
monitor sleep stage (30s 
epoch) 
Total AHI Sum of apnea and 
hypopnea events (per 
hour) 
 
Table 5: Summary of variables pertinent to analysis, their definitions, and how 
they were measured.42 
Abbreviations: EEG, electroencephalography; EMG, electromyography; AHI, apnea-
hypopnea index.  
aProprietary threshold defined by Philips Respironics.  
 
Statistical Analysis 
All data were entered into a Microsoft Excel (2016; Microsoft, Redmond, WA) 
spreadsheet. Each demographic variable was reported using descriptive statistics 
(mean and percentage). Continuous variables were described as means with 95% 





second epoch) were obtained from each patient. Respiratory event annotations were 
also obtained for each of the epochs—including apneas, hypopneas, respiratory 
events, arousals, and total AHI.  
 
The intrinsic relationships between individual predictors thus collected were assessed 
first by Pearson correlation coefficients and associated P values. A correlation matrix 
was graphically constructed for visualization of the relationships. Statistically 
significant pairwise correlations were identified. 
 
To identify the differences between four principal sleep-related states (awake, apnea, 
hypopnea, and asleep), an empiric cumulative distribution function (CDF) was 
plotted. The CDF calculates the cumulative probability for a given value of the x-
axis. A CDF provides probability that a data value is less than or equal to a certain 
value, higher than a certain value, or between two values. 
 
After plotting a CDF, a Q-Q plot was used to demonstrate the non-parametric nature 
of this dataset. A Q-Q plot is a probability plot that compares two probability 
distributions by plotting their quantiles. The statistical differences between actigraphy 
counts plotted as a function of the sleep state were identified by a Kruskal-Wallis 
rank sum test. The Kruskal-Wallis rank sum test is used to determine statistically 
significant differences between 3 or more groups with a non-parametric dataset. A 





differences between groups. A boxplot was constructed to identify the differences 
between the distributions of the data.  
 
Two ML algorithms were selected for modeling the data collected in this experiment: 
Linear discriminant analysis (LDA) and conditional inference tree. Both of these 
algorithms are used when the output variable is known (supervised) and both have 
discrete output variables (classifiers). Conditional inference tree is a type of 
classification and regression tree (CART), in which the predicted outcome is the class 
to which the data belongs. Conditional inference trees are structured to provide 
separation between classes, with multiple test procedures applied to determine 
whether there is no significant association between the predictor and the response 
variables.64 
 
The utility of actigraphy counts with oximetry to predict the severity of OSA was 
investigated using LDA. Linear discriminant analysis takes a data set of patients and 
their characteristics that include (i) severity of OSA diagnosed as mild, moderate, or 
severe, (ii) actigraphy counts from the entire duration of sleep, and (iii) number of 
respiratory events with clinically significant desaturations (> 3% from baseline). 
Linear discriminant analysis uses the input parameters to derive the coefficients of a 
scoring function for each severity class of OSA. Each function takes the numeric 
variables as arguments, described by (ii) and (iii), and obtained from a patient. Linear 
discriminant analysis scales each variable according to its OSA severity-specific 





patient to a category (OSA severity). Results were plotted with a decision boundary. 
Misclassifications were also identified.  
 
To predict the annotation obtained from a PSG (apnea, hypopnea, awake, and asleep) 
an ML model utilizing conditional inference was identified. The algorithm includes a 
5-fold cross-validation that included training using 80% of the data chosen randomly 
(training), and subsequently applied to the rest of the data (20%, test). Classification 
ability of the ML algorithm ascertained from the test dataset was assessed using a 
receiver operating characteristic (ROC) analysis, plotting the true positive rate vs. the 
false positive rate (or sensitivity vs. 1-specificity). The overall prediction was 
assessed using area under the curve (AUC). Each pairwise ROC analysis was 
performed separately (e.g., apneas vs. awake, hypopneas vs. apneas, etc.) All 
statistical testing was performed using the R statistical system (v4.3, www.r-





Chapter 3: Results 
Demographics and Clinical Characteristics 
The demographic and clinical characteristics of the children are summarized in Table 
6. Most children (70%) were younger than 6 years old. The male to female ratio was 
3:2. The majority were Hispanic or Black (7, 70%). Allergic rhinitis was seen in 7 
children (70%), of whom 3 were on intranasal corticosteroids. Most children (6, 60%) 
had tonsillar hypertrophy (grade 3 or 4). Mild asthma was present in 20% of patients, 
of whom only one was managed with a bronchodilator. Snoring was present in 100% 
of children, while nocturnal enuresis was only present in 10% of children.  
 
Characteristic Value 
Age, mean (95% CI) 5.8 (3.1 to 8.5) 
Gender, n (%)  
Male 6 (60) 
Female 4 (40) 
Ethnicity, n (%)  
Hispanic 1 (10) 
Black 6 (60) 
White 2 (20) 
Other 1 (10) 
Snoring, n (%) 10 (100) 
Allergic rhinitis, n (%) 7 (70) 
Asthma, n (%) 1 (10) 
Gastroesophageal reflux disease, n (%) 0 (0) 
Nocturnal enuresis, n (%) 1 (10) 
Body mass index z-scorea, mean (95% 
CI) 
0.69 (-0.15 to 1.47) 
Tonsil sizeb, mean (95% CI) 2.6 (2.3 to 2.9) 
Table 6: Demographics and Clinical Characteristics of the Study Population (n = 
10).  
Abbreviation: CI, confidence interval 
aThe body mass index z-score was calculated using Centers for Disease Control and 
Prevention data charts.63 






PSG Results  
PSGs were successfully completed in all 10 patients. The sleep efficiency was 
excellent (> 80% in all patients). The mean AHI was 16.2 (9.8 to 22.7). Moderate 
OSA (AHI  5) was seen in 30% of patients, and severe OSA (AHI  10) in 60% of 
patients. The average SpO2 nadir was 82.2 (74.1 to 90.3). A summary of PSG 
parameters obtained from the study population is provided in Table 7. 
PSG Parameter Value 
Total sleep time, min  400.6 (386.5 to 414.7) 
Sleep latency, min 30.8 (18.8 to 42.8) 
Sleep efficiency, % 87.9 (84.8 to 91.0) 
REM latency, min 201.3 (154.7 to 247.9) 
WASO, min 23.6 (16.8 to 30.4) 
REM duration, % 11.1 (9.9 to 12.3) 
Sleep stage N1 duration, % 0.08 (-0.002 to 0.2) 
Sleep stage N2 duration, % 52.2 (48.1 to 56.3) 
Sleep stage N3 duration, % 24.6 (21.4 to 27.9) 
Obstructive apneas 54.0 (24.9 to 83.1) 
Obstructive hypopneas 49.7 (23.3 to 76.1) 
Apnea index 8.9 (4.7 to 13.1) 
Hypopnea index 7.3 (3.6 to 11.0) 
Mixed apneas 0.9 (-0.1 to 1.9) 
Central apneas 5.8 (2.7 to 8.9) 
Snoring episodes 167 (51.7 to 282.3) 
Total number of respiratory events 110.4 (64.4 to 156.4) 
AHI 16.2 (9.8 to 22.7) 
Basal SpO2 97.9 (97.4 to 98.6) 
SpO2 nadir, % 82.2 (74.1 to 90.3) 
Average SpO2 during REM 97.6 (96.7 to 98.5) 
Average SpO2 during NREM 98.0 (97.4 to 98.6) 
Sleep time with SpO2 <90%, min 2.2 (0.4 to 3.9) 
Awake HR 101.1 (93.6 to 108.5) 
Arousal index 14.2 (9.2 to 19.1) 
Spontaneous arousals  19.4 (14.8 to 24.0) 
Respiratory events with desaturations 39.7 (9.0 to 70.4) 
Table 7: PSG Parameters interpreted by sleep technicians according to the 
AASM 2012 manual,42 and their values, mean (95% CI). 
Abbreviations: CI, confidence interval; REM, rapid eye movement; AHI, apnea-







The actigraph stayed on the wrist for the entire duration of sleep in all patients. No 
adverse events were noted. There were no instances of device malfunction or data 
loss. Discretized actigraphy counts were obtained successfully in all 10 patients. 
Table 8 summarizes the total counts obtained as a function of wake-sleep stage from 
all patients.  
Actigraphy Parameter Value 
Total actigraphy count (lights on to off) 9936.4 (5891.8 to 13981.0) 
Total actigraphy count (stage 2 to wake) 5947.4 (3632.0 to 8262.8) 
WASO activity acount 2708.2 (869.6 to 4546.8) 
Sleep activity (total activity from sleep 
stages minus WASO) 
3239.2 (2004.9 to 4473.5) 
Table 8: Actigraphy parameters measured by the Actiwatch-2®, and their values, 
mean (95% CI).  
Abbreviations: WASO, wake after sleep onset; CI, confidence interval. 
Statistical Analysis  
In the current study, 6 variables (actigraph counts, respiratory events with 
desaturation, arousals, apneas, hypopneas, and the AHI) were obtained from the PSGs 
and the actigraphy recordings. The relationships among these 6 parameters were 
assessed using Pearson correlation coefficients and their associated P values, as 
shown in Fig. 4. The correlation matrix demonstrates significant pairwise 
relationships among all 6 parameters. The range of correlation coefficients between 
actigraph counts and PSG parameters were from 0.23 for apneas (P = .09) to 0.67 for 






Figure 4: Correlation matrix of actigraphy counts and indices representing 
respiratory events. The color and the size of each circle indicates the magnitude of 
the pairwise correlation. Total counts correlated well with each of the respiratory 
events except apneas. The legend is provided to the right of the matrix.  
 
Actigraphy counts as a function of 4 PSG-annotated respiratory epochs (awake, 
asleep, apnea, and hypopnea events) were plotted using an empiric cumulative 
distribution function (CDF) in Fig. 5. Here, the CDFs show the probability level 
associated with actigraphy counts either greater than or less than a specific value. The 





hypopnea counts. The majority of counts obtained from the asleep and apnea 
annotations were convergent.  
 
 
Figure 5: Empirical cumulative distribution function showing distribution of 
actigraphy counts as a function of type of respiratory event. The plot 
demonstrates the proportion of the total distribution at a certain level of actigraphy 
counts grouped by annotated respiratory events (legend to the right). Higher overall 
levels of activity were seen both in the awake and hypopnea events, but there was 
little overlap between the two groups.  
 
The mean actigraphy counts were highest in the awake state (94.16 events/epoch; 
91.16 to 97.48) and lowest in the asleep state (1.37 events/epoch; 0.89 to 1.85). Next, 





rank sum test, due to the non-normal distribution of the data. The differences between 
the groups was statistically significant (2 = 9935.3, P = 10-15). Multiple pairwise 
comparisons between the different groups of actigraphy counts using Dunn’s test 
demonstrated statistically significant differences (range of P values: 10-30 to 10-5) 
except one comparison (asleep vs. apnea events, P = .14).  
 
 
Figure 6: Boxplot of overall counts grouped by annotation of respiratory events. 
Each boxplot is centered around the median with the 25th-75th percentile shown by the 
extent of the box and the whiskers spanning the range. The actigraphy counts were 
significantly higher for both awake and hypopnea annotations. Statistical comparisons 
are provided in text. 
Machine Learning  
Results from ML algorithms used in the current study are summarized in Fig. 7 and 8. 





features (mean actigraphy counts and respiratory events in each patient) to predict the 
severity class of OSA by their labels known a priori. Two separate classes emerged 
as shown by a classification boundary that divides the figure into two regions (pink 
and white). Patients labeled as 3 had AHI greater than 10 (severe OSA). Labels 1 and 
2 represented mild and moderate OSA, respectively. As is shown in Fig. 7, all but one 
patient was correctly classified as severe OSA.  
 
 
Figure 7: Plot demonstrating classification of observations based on linear 
discriminant analysis for every combination of two variables (actigraphy counts 
and respiratory events) for each patient. In addition, the classification border is 
drawn, and the misclassified patients shown in red. Respiratory events denote events 
where clinically significant deterioration in oximetry recording (> 3% drop) was 
identified.  
 
Next, results from the conditional inference tree are shown in Fig. 8 and 9. The model 
obtained from the training portion of dataset (80%) is demonstrated in Fig. 8. The tree 





Here, nodes 2 and 5 represent classifications that contain mostly asleep and awake 
annotations. Node 4 shows that the algorithm was not as effective in separating awake 
and hypopnea events. The overall structure of the tree demonstrates that the range of 
actigraphy counts between 0 and 98 was not fully resolved.  
 
Figure 8: Results from a machine learning algorithm (conditional inference tree) 
as applied to the training dataset for various classes of respiratory events. 
Visualization of this interpretable classification algorithm demonstrates the separation 
of the classification tree into “nodes.” Node 1 represents classification based on 
counts obtained from actigraphy. Node 2 shows classification results as indicated by 
proportion of patients classified correctly. For example, the majority of actigraphy 
counts related to an annotation indicating ‘asleep’ were zero. Node 3 demonstrates a 
second threshold of actigraphy counts. Based on this threshold, most patients were 
classified to be awake when their actigraphy counts exceeded 98. Associated P values 






The classification tree created by the conditional inference algorithm was 
subsequently applied to the training dataset, which constituted 20%. As the prediction 
is a multiclass problem (four distinct classes of respiratory event annotations), an 
ROC curve was constructed for each pairwise comparison. The AUC ranged from 
0.52 (apneas vs. asleep) to 0.88 (awake vs. asleep). A sample ROC is shown for 




Figure 9: Receiver operating characteristic curves of machine learning 
techniques to predict respiratory events (hypopneas events vs. asleep events). 
The figure plots false positive rate (x-axis) as a function of true positive rate (y-axis). 
Performance of the ML method is summarized by area under the curve (AUC). An 
ideal classifier has an AUC of 1, while a chance-based classifier, positioned 







Chapter 4: Discussion 
The current study used a non-invasive wrist-based movement sensor with the aim of 
capturing sleep fragmentation and arousals in children undergoing PSG. The 
preliminary results demonstrate that actigraphy counts can be reliably obtained during 
a PSG, and no adverse events were identified. Actigraphy counts correlated well with 
the respiratory event annotations from the sleep study. Linear discriminant analysis 
showed that 100% of children with severe OSA were classified correctly using 
actigraphy counts and respiratory events alone. A conditional inference model 
demonstrated that hypopnea events can be classified with high accuracy, while the 
distinction between apnea and asleep events could not be achieved effectively. These 
preliminary results support further investigation of the use of actigraphy in 
combination with pulse oximetry.  
 
The male predominance in this study population is consistent with previous studies 
that report a 3:2 male-to-female ratio.65 The presence of allergic rhinitis in most 
children is consistent with the inflammatory etiology of OSA. The mean AHI was 
16.2 (9.8 to 22.7), which would be classified as severe. Every child tested was 
diagnosed with some degree of OSA, confirming the clinician’s suspicion based on 
clinical parameters.  
 
Actigraphy counts were found to correlate strongly with all respiratory events, except 
apneas. Apneas are defined by complete cessation of airflow, and can be associated 





in movement.42 Arousals would be expected to correlate more with wrist movement 
than desaturations would, so these results are consistent. Plotting actigraphy count 
distributions as a function of respiratory event annotations showed that the highest 
activity levels were seen in the awake and hypopneic events, with little overlap 
between these two groups. However, there was no significant distinction between 
asleep and apneic events. These results show that actigraphy counts alone were not 
sufficient to detect apneic events.  
 
The combination of total actigraphy and respiratory events with LDA generated a 
decision boundary for classification of patients. Linear discriminant analysis uses 
several predictor variables to separate categorical variables with decision boundaries. 
This ML strategy projects data points into regions characterized by their vectors of 
means, or “centroids.”66 These centroids are labelled by categories, and have distinct 
linear boundaries. Linear discriminant analysis achieves this by deriving coefficients 
of a scoring algorithm (called a discriminant function) using the input data for each 
category and using the predictor variables as arguments. When evaluating an 
unknown sample, the discriminant functions output a score, and the LDA uses the 
highest score from each function to determine the nearest centroid. Then the sample is 
allocated to a category.56 Linear discriminant analysis was chosen over other 
classification ML algorithms as the results are generalizable in a clinical population, 
and are potentially more interpretable to a clinician. In this experiment, prediction is 





patient above the line would be predicted to have severe OSA, and a patient below the 
line would be predicted to have mild or moderate OSA.  
 
When this analysis attempts to stratify patients into the three categories of mild, 
moderate, and severe OSA, 20% of the patients are misclassified (those with mild 
OSA are misclassified as moderate or severe). If instead, only the two categories of 
mild/moderate and severe are separated by the decision boundary, only 10% of 
patients are misclassified (those with mild/moderate are misclassified as severe). 
Regardless, 100% of the severe OSA cases were correctly identified. A higher false 
positive rate is preferred to a higher false negative rate, as a patient with mild OSA 
misclassified as severe will simply be referred for PSG or monitored post-operatively. 
A patient with severe OSA misclassified as mild/moderate would be at risk for 
PRAEs if they were not screened further with PSG or monitored post-operatively.  
 
A decision tree resembles a flowchart, where each internal node denotes a test, each 
branch represents an outcome, and each leaf holds a class label. Conditional inference 
trees determine which variable to split based on a measure of association between 
each covariate and the outcome of interest. Then, the best split point for a variable is 
determined using statistical inference procedures. The association between each 
covariate and the outcome is quantified using a regression model, and a node is 
chosen to be split if there is sufficient evidence to reject the global null hypothesis 
(the hypothesis that none of the covariates has a univariate association with the 





determined based on maximizing the two-sample association test. Stopping rules may 
be put into place to prevent overfitting.67 A conditional inference tree was selected 
over other ML algorithms, such as SVM, because it can be easily clinically 
interpreted. Other more complicated algorithms, like SVM, may be more accurate but 
are not as easy to interpret and may require larger training datasets to function.   
 
Conditional inference has been used in the past to model intimate partner violence,68 
bioaccumulation of organic chemicals,69 and gene regulation.70 In this experiment, the 
variable of interest was actigraphy counts. The first node splits the presence or 
absence of actigraphy—when activity is 0, the patient is predicted to be asleep or 
apneic. Node 3 represents a second threshold for activity, and when the actigraphy 
count is greater than 98, the patient is predicted to be awake. When the actigraphy 
count is non-zero but less than 98, this algorithm cannot reliably distinguish between 
awake and hypopnea events. Increase in sample size is expected to improve the 
performance of the algorithm used.  
 
The principal limitation for this study was the patient sample size and lack of 
adequate statistical power. As data collection was performed over the winter, attrition 
due to illness and weather prevented recruitment of a larger population. Machine 
learning typically requires much larger sample sizes to optimize validation. 
Therefore, the results presented here are preliminary and lay the foundation for larger 





exploration of other, more complex algorithms. Improvements in the recruitment 
process have been made through partnership with an additional sleep laboratory. 
 
When developing a model for a given dataset with an appropriate predictive accuracy, 
it is necessary to avoid overfitting the data. Increasingly complex models may be able 
to fit the data exceedingly well, and eliminate residual error between the model and 
the training data, but will be unable to successfully make predictions about new 
data.56 This concept of determining the proper fit is demonstrated in Fig. 10 below. 
We attempted to prevent overfitting by refraining from the potentially more accurate 




Figure 10: Demonstration of model fit. The sample data is logarithmic: (A) shows 
underfitting (linear), (B) shows appropriate fit (logarithmic), (C) shows overfitting 





Although the utility of actigraphy was demonstrated for identifying hypopneas and 
other respiratory events, actigraphy alone cannot capture apneas. Complete cessation 
of airflow does not necessarily imply arousal. Actigraphy cannot be used on its own 
to evaluate the severity of OSA. As apneas are physiologically coupled usually with 
reduction in oxygen saturation, our future efforts will aim to identify events with a 
combination of oximetry and actigraphy for capturing a greater proportion of 
respiratory events. 
 
Using the Actiwatch-2® has limitations as well. This proprietary technology utilizes a 
solid-state piezo-electric accelerometer with a certain, unknown threshold for 
detecting movement. These actigraphs are also expensive, costing around $700. This 
estimated cost does not include the required docking-station, and software necessary 
for data retrieval. The ultimate goal of this project is to design and build a budget-
conscious actigraph, but further experiments would be warranted to optimize the 







Chapter 5:  Conclusions and Future Directions 
 
The preliminary results presented here provide a framework for home-based risk 
stratification of pediatric OSA. Actigraphy and home oximetry could be simple, cost-
effective and reliable instruments for screening for OSA. Our results and future 
directions may provide a logical outline for two sleep centers—one to screen, and the 
other to further validate higher risk children. This model can hopefully reduce the 
burden on current sleep centers, assist clinicians in decision making, decrease 
resource utilization, and more importantly, reduce the discomfort to children and their 
families in the current model of obtaining PSGs in all children.  
 
Combining real-time oximetry data with actigraphy would theoretically provide 
information about both apneas (desaturations) and hypopneas (arousals). Adding this 
data could enhance the machine learning algorithms and improve their predictive 
capability. An actigraph and a finger-based pulse-oximeter could easily and 
conveniently be implemented as an HSAT if further research can validate their 
combined use.  
 
The current classification border is able to classify patients with mild/moderate OSA 
and severe OSA. Children classified as severe using this analysis could either be 
referred for follow-up PSG, or simply monitored for PRAEs post-T&A. Further 
research could be performed to evaluate the effectiveness, cost, and safety of these 






A budgeted regression analysis should be performed to determine the cost-
effectiveness of screening with actigraphy vs. PSG alone. Previous studies have 
estimated 1,000 children can be evaluated by PSG with $1,000,000;41 the number of 
children that could be effectively screened using actigraphy (with or without 
oximetry) with $1,000,000 should be determined. Ultimately, a cost-conscious device 
should be built and evaluated using the same budgeted regression analysis.   
 
This cost-conscious device could be achieved by using linear accelerometers to 
capture 3 degrees of linear acceleration, and rotational accelerometers or gyroscopes 
to capture 3 degrees of rotational movement. In total, this actigraph would have 6 
degrees of freedom. Early prototypes have been developed using an Arduino® board 
(Arduino, Somerville, MA), an open source hardware and software company that 
manufactures computer boards. Such an actigraph would provide a continuous 
distribution of the accelerometry data. Other components could be added to the board, 
such as a simple heart rate monitor. Heart rate increases during arousals, and this 
could be used in combination with the actigraphy data to improve detection of apneas 
and hypopneas. Further considerations for device design include: battery life, memory 
(data storage), size of the watch, and cost for both development and production. 
Ultimately, this device could provide a cost-conscious solution to current issues with 
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